Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malaria

  Free Subscription


01.05.2017

1 Am J Trop Med Hyg
2 Clin Infect Dis
1 Infect Immun
1 Lancet Infect Dis
11 Malar J
1 N Engl J Med
3 PLoS One
1 PLoS Pathog
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Trop Med Hyg

  1. VIEIRA JL, Ferreira MES, Ferreira MVD, Gomes MM, et al
    Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to Plasmodium vivax in the Brazilian Amazon Basin.
    Am J Trop Med Hyg. 2017 Apr 3. doi: 10.4269/ajtmh.15-0368.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  2. DAVIS NL, Wiener J, Juliano JJ, Adair L, et al
    Co-trimoxazole prophylaxis, asymptomatic malaria parasitemia, and infectious morbidity in HIV-exposed uninfected infants in Malawi: The BAN study.
    Clin Infect Dis. 2017 Apr 21. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. CHICO RM, Chaponda EB, Ariti C, Chandramohan D, et al
    Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections.
    Clin Infect Dis. 2017;64:1043-1051.
    PubMed     Text format     Abstract available


    Infect Immun

  4. RAJA AI, Stanisic DI, Good MF
    Chemical attenuation in the development of a whole organism malaria vaccine.
    Infect Immun. 2017 Apr 24. pii: IAI.00062-17. doi: 10.1128/IAI.00062.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  5. THE LANCET INFECTIOUS DISEASES
    Is malaria elimination within reach?
    Lancet Infect Dis. 2017;17:461.
    PubMed     Text format    


    Malar J

  6. TOUGHER S, Hanson K, Goodman C
    What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
    Malar J. 2017;16:173.
    PubMed     Text format     Abstract available

  7. PHOK S, Lek D
    Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies.
    Malar J. 2017;16:171.
    PubMed     Text format     Abstract available

  8. OMURA S, Crump A
    Ivermectin and malaria control.
    Malar J. 2017;16:172.
    PubMed     Text format     Abstract available

  9. RICHARDS FO JR
    Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria.
    Malar J. 2017;16:168.
    PubMed     Text format     Abstract available

  10. PHANALASY S
    The malaria testing and treatment landscape in the southern Lao People's Democratic Republic (PDR).
    Malar J. 2017;16:169.
    PubMed     Text format     Abstract available

  11. CHACCOUR C, Rabinovich NR
    Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways.
    Malar J. 2017;16:162.
    PubMed     Text format     Abstract available

  12. CHACCOUR C, Rabinovich NR
    Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway.
    Malar J. 2017;16:166.
    PubMed     Text format     Abstract available

  13. GEBRU T, Ajua A, Theisen M, Esen M, et al
    Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.
    Malar J. 2017;16:176.
    PubMed     Text format     Abstract available

  14. AREGAWI M, Malm KL, Wahjib M, Kofi O, et al
    Effect of anti-malarial interventions on trends of malaria cases, hospital admissions and deaths, 2005-2015, Ghana.
    Malar J. 2017;16:177.
    PubMed     Text format     Abstract available

  15. ZINSOU C, Cherifath AB
    The malaria testing and treatment landscape in Benin.
    Malar J. 2017;16:174.
    PubMed     Text format     Abstract available

  16. CHACCOUR C, Hammann F, Rabinovich NR
    Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety.
    Malar J. 2017;16:161.
    PubMed     Text format     Abstract available


    N Engl J Med

  17. KORN T, Oukka M
    A BAFFling Association between Malaria Resistance and the Risk of Multiple Sclerosis.
    N Engl J Med. 2017;376:1680-1681.
    PubMed     Text format    


    PLoS One

  18. SRISUTHAM S, Saralamba N, Malleret B, Renia L, et al
    Four human Plasmodium species quantification using droplet digital PCR.
    PLoS One. 2017;12:e0175771.
    PubMed     Text format     Abstract available

  19. MARCOMBE S, Bobichon J, Somphong B, Phommavan N, et al
    Insecticide resistance status of malaria vectors in Lao PDR.
    PLoS One. 2017;12:e0175984.
    PubMed     Text format     Abstract available

  20. TEKLEMARIAM M, Assefa A, Kassa M, Mohammed H, et al
    Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia.
    PLoS One. 2017;12:e0176004.
    PubMed     Text format     Abstract available


    PLoS Pathog

  21. REVERCHON F, Mortaud S, Sivoyon M, Maillet I, et al
    IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria.
    PLoS Pathog. 2017;13:e1006322.
    PubMed     Text format     Abstract available


    Vaccine

  22. CHATTOPADHYAY R, Pratt D
    Role of controlled human malaria infection (CHMI) in malaria vaccine development: A U.S. food & drug administration (FDA) perspective.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30406.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malaria is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: